Tetragon has released its Monthly Factsheet for April 2024.
- Net Asset Value: $ 2,780m- Fully Diluted NAV Per Share: $31.28- Share Price (TFG NA): $9.86- Monthly NAV per share total return: 1.1%- Monthly Return on Equity: -0.6%- Most recent.
Hedge funds – how to diversify your portfolio moneyweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneyweek.com Daily Mail and Mail on Sunday newspapers.
Aardvark Therapeutics secures $85m in Series C funding round pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.